Last reviewed · How we verify

NCT04230525

Body Impedance Method in Patients Undergoing Urgent and Elective Cesarian Section

Status unknown Last updated 8 March 2021
What this trial tests

trial testing non invasive whole body bioimpedence system in Cesarean Section Complications in 95 participants. Status unknown.

Timeline
5 March 2020
Primary endpoint
5 June 2020
10 June 2021

Quick facts

Lead sponsorGaziosmanpasa Research and Education Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment95
Start date5 March 2020
Primary completion5 June 2020
Estimated completion10 June 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Gaziosmanpasa Research and Education Hospital

Who can join

Adults 18 to 49, female only, with Cesarean Section Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Independent form anesthetic methods, during C/S, considering both maternal and fetal conditions, some crucial hemodynamic changes can appear and can be claimed non invasively with the whole body bioimpedance. In this research, any kind of hemodynamic difference between this method and urgent or elective C/S case will be detected and the clinic pursuit can be developed creating an advantage in favor of both maternal and fetal conditions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cesarean Section Complications

Currently open trials in the same condition.

Other Gaziosmanpasa Research and Education Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04230525.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing